Results 201 to 210 of about 29,106 (245)

Plasmids, prophages, and defense systems are depleted from plant microbiota genomes. [PDF]

Genome Biol
Bograd A, Oppenheimer-Shaanan Y, Levy A.
europepmc   +1 more source

Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade

Molecular Oncology, EarlyView.
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley   +1 more source

Decoding the evolutionary history of ST30 <i>Staphylococcus aureus</i>: insights into a potentially silent MSSA bloodstream pathogen. [PDF]

Front Microbiol
Esteves MAC, Carvalho MF, Viana AS, Martini CL, Longo LGA, Silva DNS, Ferreira ALP, Ferreira-Carvalho BT, Planet PJ, Figueiredo AMS.   +9 more
europepmc   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Uncovering the integral spectral characteristics of the planetary nebula IC 4642. [PDF]

Sci Rep
Mohery M, Ali A, Hamam KA, Khames AA, Alsubaie AS.   +4 more
europepmc   +1 more source

Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management

Molecular Oncology, EarlyView.
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez, Asieh Naderi, Kim‐Tuyen Huynh‐Dam, Vitali Sikirzhytski, Ioulia Chatzistamou, Hippokratis Kiaris   +5 more
wiley   +1 more source

Small modifier, big decision: switching to SUMO mode adds weight to cancer stemness in mammary tumors

Molecular Oncology, EarlyView.
Inhibition of protein SUMOylation has been shown to block tumorigenesis; however, the specific mechanisms by which SUMOylation controls the tumor‐initiating capacities remain elusive. Li et al. describe the role of Etv1 SUMOylation in cancer stem cells using mouse models of mammary gland tumorigenesis.
Veronika Yevdokimova, Yannick D. Benoit
wiley   +1 more source

The dramatic transition of the extreme Red Supergiant WOH G64 to a Yellow Hypergiant

Munoz-Sanchez G, Kalitsounaki M, de Wit S, Antoniadis K, Bonanos A, Zapartas E, Boutsia K, Christodoulou E, Maravelias G, Soszyński I, Udalski A.   +10 more
europepmc   +1 more source

Dual Antibacterial and Soft-Tissue-Integrative Effect of Combined Strontium Acetate and Silver Nitrate on Peri-Implant Environment: Insights from Multispecies Biofilms and a 3D Coculture Model. [PDF]

ACS Appl Mater Interfaces
Kheirmand-Parizi M, Doll-Nikutta K, Mikolai C, Wirth D, Menzel H, Stiesch M.   +5 more
europepmc   +1 more source